Bismuth Subnitrate
Indication
1. Primary or secondary male sexual dysfunction. 2. Male puberty retardation. 3. Palliative treatment of advanced breast cancer in postmenopausal women.
Manufacturer
Hunan Xiangyikang Pharmaceutical Co., Ltd.
-
Founded in:
2009-01-05 -
Address:
Datong Lake District, Yiyang City, Hunan Province -
Tax NO.:
914309006828327274 -
Registered Funds:
10 million yuan -
Email: